Upharmacia July 2017
CIS REGION NEWS
A zerbaijan
— — Sun Pharma started the
construction of its GMP plant
for the production of solid drugs in Sumqayit. The
company plans launch the production in the end of
2018. The production will be exported into CIS and
other external markets.
— — Bulgarian companies are interested in the Pirallahi
Industrial Park and currently exploring the
possibilitie s for future cooperation. Currently, 3
pharmaceutical plants are being constructed in
the Pirallahi Industrial Park: a joint venture with a
group of companies R-Pharm (Russian Federation),
Vita-A LLC (Azerbaijan) and Azerbaijan Investment
Company (AIC); The joint pharmaceutical plant
between Iranian company Tamin Pharmaceutical
Investment Company (TPIC) and Azerbaijan’s
Azersun Holding and the Azerbaijani company
Diamed Co.
B elarus
— — International Scientific and
Production Complex Nativita was
opened in Beshankovichy. The plant
is designed to produce innovative drugs for the
treatment of oncology diseases. The company plans
close cooperation with other companies in research
and development.
finished in 2019.
— — Russian Fund for Industrial Development approved
the provision of the loan for establishing of the
manufacturing of hepatitis A vaccine at the facilities
of JSC Vector-BiAlgam in Novosibirsk.
— — Russian Group of Companies R-Pharm obtained
license from Otsuka Novel Products GmbH for the
production and marketing of delamanid for the
treatment of tuberculosis.
K azakhstan
— — SK-Pharmaceuticals resumes supplying
insuline glargine and blood glucose
test strips for all patients with diabetes
and interferon beta-1b for all patients
with the multiple sclerosis. All medicines will be
provided for patients for the free of charge within
the framework of the state-guaranteed free medical
care.
— — Compulsory vaccination is being discussed now
in the country. Recently in Kazakhstan there are
more and more frequent refusals of vaccination on
religious beliefs.
— — The MoH widened the list of medicines which will be
100% reimbursed for all patients with 59 items. The
new list comes into force on Jan 1, 2018.
— — A pharmaceutical holding company will be
established in Belarus. The holding company will be
open for enterprises of all forms of ownership and
any departmental affiliation.
R ussia
— — Distribution company ROSTA sold its
pharmacy chains Raduga, Pervaya
Pomosh and Ladushka to Erkapharm
Group of Companies. All these chains include 1191
pharamcies.
— — Indian company Hetero labs intends to establish
pharmaceutical production of essential drugs in Tula
region.
— — Mir-Pharm company signed investment contract on
intention to build the plant in Kaluga pharmaceutical
cluster. The project will demand investments of
about RUB 450 mio. The construction is planed to be
10
www.upharma-c.com